TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Injeksjonsspesialisten AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
13,348
|
13,687
|
13,313 |
Financial expenses |
6
|
3
|
2 |
Earnings before taxes |
4,113
|
3,621
|
2,030 |
Total assets |
6,340
|
7,098
|
7,909 |
Current assets |
5,724
|
6,350
|
7,061 |
Current liabilities |
5,309
|
6,244
|
3,654 |
Equity capital |
1,019
|
833
|
4,232 |
- share capital |
30
|
32
|
31 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
16.1%
|
11.7%
|
53.5% |
Turnover per employee | |||
Profit as a percentage of turnover |
30.8%
|
26.5%
|
15.2% |
Return on assets (ROA) |
65.0%
|
51.1%
|
25.7% |
Current ratio |
107.8%
|
101.7%
|
193.2% |
Return on equity (ROE) |
403.6%
|
434.7%
|
48.0% |
Change turnover |
568
|
-38
|
-715 |
Change turnover % |
4%
|
0%
|
-5% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.